Share Price and Basic Stock Data
Last Updated: December 9, 2025, 2:18 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Everlon Financials Ltd operates as a Non-Banking Financial Company (NBFC), a sector that has seen significant fluctuations in recent years. The company’s revenue trajectory has been erratic, with sales of โน5.25 Cr reported for FY 2023, a stark contrast to the โน53.40 Cr recorded in FY 2014. The latest figures show an uptick, with TTM sales at โน16.81 Cr, indicating potential recovery. However, the company’s quarterly sales have shown inconsistency, notably peaking in Jun 2025 at โน8.23 Cr, while other quarters have seen much lower performance. Such volatility raises questions about the underlying demand for its services and the effectiveness of its operational strategies. The cash conversion cycle, which stood at a staggering 666.58 days recently, suggests that the company is struggling with efficiency in converting its investments into cash flow, which could be a concern for potential investors.
Profitability and Efficiency Metrics
When examining profitability, Everlon’s financials present a mixed picture. The operating profit margin (OPM) has fluctuated dramatically, recently recording -4.25% in Jun 2025, contrasting sharply with a high of 326.62% in Dec 2024. This volatility hints at challenges in cost management and operational efficiency. The return on equity (ROE) stands at a modest 4.69%, indicating that the company is generating limited returns relative to shareholders’ equity. However, the return on capital employed (ROCE) of 16.7% appears more favorable, suggesting that once capital is deployed, it can generate reasonable returns. While net profit for the latest reporting period was -โน1.20 Cr, the prior year showed a net profit of โน1.35 Cr, reflecting an ongoing struggle to maintain profitability amidst operational challenges.
Balance Sheet Strength and Financial Ratios
Everlon Financials’ balance sheet reveals a relatively debt-free position, with borrowings reported as โน0.00 Cr, which is a significant strength in todayโs financial landscape. The company has increased its reserves from โน4.38 Cr in FY 2023 to โน25.05 Cr in FY 2025, reflecting an improving capital base. However, the price-to-book value (P/BV) ratio of 1.18x suggests that the stock is trading at a premium compared to its book value, which may appear stretched in light of its inconsistent earnings. The interest coverage ratio (ICR) of 2.13x indicates that the company can comfortably cover interest obligations, but with no debt currently on the books, this metric may not fully reflect future borrowing potential. The overall financial ratios point towards a cautious but improving financial health, though the volatility in operational metrics warrants close scrutiny.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Everlon Financials reveals a strong promoter holding of 74.47%, which can be interpreted as a positive signal of management confidence in the companyโs future. However, the public shareholding has decreased to 25.53%, down from 28.16% in Dec 2022. This decline may indicate waning investor confidence, possibly due to the company’s inconsistent financial performance. The number of shareholders has also seen fluctuations, with a recent count of 2,727, down from 2,673 in Dec 2022. This trend could suggest that retail investors are becoming cautious amid the company’s financial volatility. A high promoter stake can be seen as a double-edged sword; while it indicates commitment, it can also lead to concerns about transparency and governance if not balanced with broader public participation.
Outlook, Risks, and Final Insight
Looking ahead, Everlon Financials faces a challenging landscape. The company must address its operational inefficiencies to stabilize its revenue and profitability. The high cash conversion cycle is a significant risk, as it indicates potential liquidity issues that could affect operational flexibility. Moreover, while the lack of debt is a strength, it also raises questions about the company’s growth strategy and whether it is under-leveraged in a competitive market. Investors should be wary of the wide fluctuations in profitability metrics, as these could signal deeper operational or market challenges. In a sector that often rewards consistent performance, Everlon’s erratic financials may deter potential investors. Thus, while there are strengths in its balance sheet and promoter commitment, the overarching volatility and operational challenges present significant risks that need to be navigated carefully.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Everlon Financials Ltd โ Key Insights and Financials.
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 11.0 Cr. | 1.10 | 1.91/1.00 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 | |
| Money Masters Leasing & Finance Ltd | 9.54 Cr. | 0.95 | 9.18/0.85 | 28.0 | 1.57 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 437 Cr. | 134 | 269/130 | 80.1 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 15.4 Cr. | 16.8 | 35.2/15.0 | 11.4 | 26.6 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 37.0 Cr. | 82.3 | 176/74.8 | 19.8 | 238 | 1.21 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 29,949.03 Cr | 440.43 | 52.25 | 522.84 | 0.22% | 15.80% | 8.84% | 8.50 |
All Competitor Stocks of Everlon Financials Ltd โ Key Insights and Financials.
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 4.72 | 0.43 | 1.45 | 4.46 | 1.68 | 2.52 | 4.53 | 3.36 | 1.39 | 3.83 | 8.23 |
| Expenses | 0.06 | 0.13 | 2.50 | 0.43 | 0.06 | 3.14 | -0.01 | -2.10 | 2.47 | 2.78 | -3.15 | 9.11 | 8.58 |
| Operating Profit | -0.06 | -0.13 | 2.22 | 0.00 | 1.39 | 1.32 | 1.69 | 4.62 | 2.06 | 0.58 | 4.54 | -5.28 | -0.35 |
| OPM % | 47.03% | 0.00% | 95.86% | 29.60% | 100.60% | 183.33% | 45.47% | 17.26% | 326.62% | -137.86% | -4.25% | ||
| Other Income | 0.08 | 0.23 | -0.20 | 0.03 | 0.02 | 0.02 | 0.06 | 0.02 | 0.00 | 0.00 | 2.44 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.02 | 0.02 | 0.01 | 0.00 | 0.01 |
| Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 |
| Profit before tax | 0.00 | 0.08 | 2.00 | 0.01 | 1.40 | 1.32 | 1.71 | 4.61 | 2.02 | 0.54 | 6.94 | -5.31 | -0.38 |
| Tax % | 0.00% | 6.00% | 6,300.00% | 33.57% | 33.33% | -43.27% | 19.31% | 2.48% | 18.52% | 35.73% | 7.16% | 7.89% | |
| Net Profit | 0.00 | 0.08 | 1.89 | -0.62 | 0.93 | 0.88 | 2.44 | 3.73 | 1.98 | 0.43 | 4.46 | -5.68 | -0.41 |
| EPS in Rs | 0.00 | 0.14 | 3.36 | -1.10 | 1.65 | 1.42 | 3.94 | 6.02 | 3.19 | 0.69 | 7.19 | -9.16 | -0.66 |
Last Updated: August 19, 2025, 3:46 pm
Below is a detailed analysis of the quarterly data for Everlon Financials Ltd โ Key Insights and Financials. based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 8.23 Cr.. The value appears strong and on an upward trend. It has increased from 3.83 Cr. (Mar 2025) to 8.23 Cr., marking an increase of 4.40 Cr..
- For Expenses, as of Jun 2025, the value is 8.58 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.11 Cr. (Mar 2025) to 8.58 Cr., marking a decrease of 0.53 Cr..
- For Operating Profit, as of Jun 2025, the value is -0.35 Cr.. The value appears strong and on an upward trend. It has increased from -5.28 Cr. (Mar 2025) to -0.35 Cr., marking an increase of 4.93 Cr..
- For OPM %, as of Jun 2025, the value is -4.25%. The value appears strong and on an upward trend. It has increased from -137.86% (Mar 2025) to -4.25%, marking an increase of 133.61%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.00 Cr. (Mar 2025) to 0.01 Cr., marking an increase of 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.02 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.03 Cr. (Mar 2025) to 0.02 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is -0.38 Cr.. The value appears strong and on an upward trend. It has increased from -5.31 Cr. (Mar 2025) to -0.38 Cr., marking an increase of 4.93 Cr..
- For Tax %, as of Jun 2025, the value is 7.89%. The value appears to be increasing, which may not be favorable. It has increased from 7.16% (Mar 2025) to 7.89%, marking an increase of 0.73%.
- For Net Profit, as of Jun 2025, the value is -0.41 Cr.. The value appears strong and on an upward trend. It has increased from -5.68 Cr. (Mar 2025) to -0.41 Cr., marking an increase of 5.27 Cr..
- For EPS in Rs, as of Jun 2025, the value is -0.66. The value appears strong and on an upward trend. It has increased from -9.16 (Mar 2025) to -0.66, marking an increase of 8.50.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 53.40 | 41.03 | 30.97 | 39.23 | 36.68 | 39.62 | 37.34 | 34.04 | 35.40 | 5.25 | 10.19 | 15.55 | 16.81 |
| Expenses | 52.16 | 39.90 | 30.55 | 38.53 | 35.95 | 39.49 | 36.74 | 32.53 | 34.62 | 3.11 | 1.06 | 11.22 | 17.32 |
| Operating Profit | 1.24 | 1.13 | 0.42 | 0.70 | 0.73 | 0.13 | 0.60 | 1.51 | 0.78 | 2.14 | 9.13 | 4.33 | -0.51 |
| OPM % | 2.32% | 2.75% | 1.36% | 1.78% | 1.99% | 0.33% | 1.61% | 4.44% | 2.20% | 40.76% | 89.60% | 27.85% | -3.03% |
| Other Income | 0.01 | 0.05 | 0.57 | 0.04 | 0.10 | 0.04 | 0.03 | -0.67 | 1.99 | 0.04 | 0.04 | 0.00 | 2.44 |
| Interest | 0.64 | 0.78 | 0.66 | 0.35 | 0.32 | 0.31 | 0.24 | 0.32 | 0.24 | 0.01 | 0.02 | 0.04 | 0.04 |
| Depreciation | 0.30 | 0.31 | 0.23 | 0.22 | 0.22 | 0.25 | 0.23 | 0.22 | 0.22 | 0.07 | 0.08 | 0.10 | 0.10 |
| Profit before tax | 0.31 | 0.09 | 0.10 | 0.17 | 0.29 | -0.39 | 0.16 | 0.30 | 2.31 | 2.10 | 9.07 | 4.19 | 1.79 |
| Tax % | 19.35% | 22.22% | 20.00% | 23.53% | 20.69% | 0.00% | 0.00% | 73.33% | 8.66% | 35.24% | 11.69% | 71.60% | |
| Net Profit | 0.25 | 0.07 | 0.08 | 0.14 | 0.23 | -0.39 | 0.16 | 0.08 | 2.11 | 1.35 | 8.00 | 1.19 | -1.20 |
| EPS in Rs | 0.45 | 0.12 | 0.14 | 0.25 | 0.41 | -0.69 | 0.28 | 0.14 | 3.75 | 2.40 | 12.90 | 1.92 | -1.94 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -72.00% | 14.29% | 75.00% | 64.29% | -269.57% | 141.03% | -50.00% | 2537.50% | -36.02% | 492.59% | -85.12% |
| Change in YoY Net Profit Growth (%) | 0.00% | 86.29% | 60.71% | -10.71% | -333.85% | 410.59% | -191.03% | 2587.50% | -2573.52% | 528.61% | -577.72% |
Everlon Financials Ltd โ Key Insights and Financials. has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | -16% |
| 3 Years: | -24% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 33% |
| 5 Years: | 51% |
| 3 Years: | 42% |
| TTM: | -113% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 67% |
| 3 Years: | 63% |
| 1 Year: | -12% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 18% |
| 3 Years: | 21% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 3:26 pm
Balance Sheet
Last Updated: December 4, 2025, 2:51 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.03 | 3.03 | 5.62 | 5.62 | 5.62 | 5.62 | 5.62 | 5.62 | 5.62 | 5.62 | 6.20 | 6.20 | 6.20 |
| Reserves | -1.06 | -1.00 | 0.09 | 0.23 | 0.46 | 0.63 | 0.79 | 0.92 | 3.03 | 4.38 | 13.25 | 25.05 | 18.41 |
| Borrowings | 7.45 | 7.30 | 4.80 | 3.04 | 4.66 | 3.46 | 2.33 | 4.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 1.34 | 0.96 | 0.94 | 0.91 | 1.56 | 0.96 | 0.91 | 1.05 | 0.17 | 0.29 | 0.27 | 3.08 | 3.52 |
| Total Liabilities | 10.76 | 10.29 | 11.45 | 9.80 | 12.30 | 10.67 | 9.65 | 11.94 | 8.82 | 10.29 | 19.72 | 34.33 | 28.13 |
| Fixed Assets | 3.96 | 3.80 | 3.80 | 3.59 | 3.49 | 3.34 | 3.11 | 2.89 | 0.21 | 0.15 | 0.26 | 0.26 | 0.15 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.02 | 0.03 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 14.78 | 10.02 |
| Other Assets | 6.78 | 6.46 | 7.62 | 6.21 | 8.81 | 7.33 | 6.54 | 8.83 | 8.61 | 10.14 | 19.46 | 19.29 | 17.96 |
| Total Assets | 10.76 | 10.29 | 11.45 | 9.80 | 12.30 | 10.67 | 9.65 | 11.94 | 8.82 | 10.29 | 19.72 | 34.33 | 28.13 |
Below is a detailed analysis of the balance sheet data for Everlon Financials Ltd โ Key Insights and Financials. based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 6.20 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.20 Cr..
- For Reserves, as of Sep 2025, the value is 18.41 Cr.. The value appears to be declining and may need further review. It has decreased from 25.05 Cr. (Mar 2025) to 18.41 Cr., marking a decrease of 6.64 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 3.52 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.08 Cr. (Mar 2025) to 3.52 Cr., marking an increase of 0.44 Cr..
- For Total Liabilities, as of Sep 2025, the value is 28.13 Cr.. The value appears to be improving (decreasing). It has decreased from 34.33 Cr. (Mar 2025) to 28.13 Cr., marking a decrease of 6.20 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.26 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.11 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 10.02 Cr.. The value appears to be declining and may need further review. It has decreased from 14.78 Cr. (Mar 2025) to 10.02 Cr., marking a decrease of 4.76 Cr..
- For Other Assets, as of Sep 2025, the value is 17.96 Cr.. The value appears to be declining and may need further review. It has decreased from 19.29 Cr. (Mar 2025) to 17.96 Cr., marking a decrease of 1.33 Cr..
- For Total Assets, as of Sep 2025, the value is 28.13 Cr.. The value appears to be declining and may need further review. It has decreased from 34.33 Cr. (Mar 2025) to 28.13 Cr., marking a decrease of 6.20 Cr..
Notably, the Reserves (18.41 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -6.21 | -6.17 | -4.38 | -2.34 | -3.93 | -3.33 | -1.73 | -2.84 | 0.78 | 2.14 | 9.13 | 4.33 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 16.88 | 17.88 | 24.63 | 16.38 | 31.54 | 19.44 | 9.58 | 31.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Days | 17.36 | 20.42 | 44.35 | 31.58 | 56.61 | 46.47 | 53.50 | 61.72 | 53.88 | 1,252.72 | 666.94 | |
| Days Payable | 7.29 | 8.08 | 8.95 | 6.72 | 11.82 | 4.78 | 5.40 | 7.92 | 0.26 | 3.00 | 0.35 | |
| Cash Conversion Cycle | 26.96 | 30.22 | 60.02 | 41.24 | 76.33 | 61.13 | 57.68 | 85.54 | 53.62 | 1,249.71 | 0.00 | 666.58 |
| Working Capital Days | -1.30 | -6.32 | 25.22 | 21.68 | 25.97 | 27.45 | 31.87 | 31.85 | 43.00 | 602.77 | 646.54 | 388.24 |
| ROCE % | 10.49% | 9.28% | 2.62% | 5.26% | 5.60% | -0.78% | 4.23% | 13.86% | 5.83% | 22.63% | 61.46% | 16.69% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 12 | Mar 11 | Mar 10 |
|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 1.63 | 1.13 | 1.95 |
| Diluted EPS (Rs.) | 1.63 | 1.13 | 1.95 |
| Cash EPS (Rs.) | 2.26 | 2.21 | 2.73 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 8.47 | 6.85 | 5.72 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 8.47 | 6.85 | 5.72 |
| Revenue From Operations / Share (Rs.) | 84.38 | 51.90 | 15.83 |
| PBDIT / Share (Rs.) | 2.49 | 3.21 | 3.53 |
| PBIT / Share (Rs.) | 1.86 | 2.13 | 2.76 |
| PBT / Share (Rs.) | 2.03 | 1.30 | 2.00 |
| Net Profit / Share (Rs.) | 1.63 | 1.13 | 1.95 |
| NP After MI And SOA / Share (Rs.) | 1.63 | 1.13 | 1.95 |
| PBDIT Margin (%) | 2.94 | 6.19 | 22.31 |
| PBIT Margin (%) | 2.20 | 4.11 | 17.41 |
| PBT Margin (%) | 2.40 | 2.50 | 12.61 |
| Net Profit Margin (%) | 1.93 | 2.18 | 12.33 |
| NP After MI And SOA Margin (%) | 1.93 | 2.18 | 12.33 |
| Return on Networth / Equity (%) | 19.27 | 16.51 | 34.11 |
| Return on Capital Employeed (%) | 10.47 | 17.68 | 25.48 |
| Return On Assets (%) | 6.11 | 5.53 | 16.03 |
| Long Term Debt / Equity (X) | 1.05 | 0.73 | 0.89 |
| Total Debt / Equity (X) | 1.73 | 1.15 | 0.89 |
| Asset Turnover Ratio (%) | 3.57 | 3.18 | 0.00 |
| Current Ratio (X) | 1.74 | 1.33 | 4.87 |
| Quick Ratio (X) | 0.65 | 0.68 | 3.45 |
| Inventory Turnover Ratio (X) | 10.05 | 12.88 | 0.00 |
| Interest Coverage Ratio (X) | 2.13 | 3.86 | 4.65 |
| Interest Coverage Ratio (Post Tax) (X) | 1.26 | 2.25 | 3.57 |
| Enterprise Value (Cr.) | 12.15 | 10.63 | 7.98 |
| EV / Net Operating Revenue (X) | 0.28 | 0.40 | 0.99 |
| EV / EBITDA (X) | 9.67 | 6.55 | 4.47 |
| MarketCap / Net Operating Revenue (X) | 0.11 | 0.26 | 0.71 |
| Price / BV (X) | 1.18 | 2.01 | 1.97 |
| Price / Net Operating Revenue (X) | 0.11 | 0.26 | 0.71 |
| EarningsYield | 0.16 | 0.08 | 0.17 |
After reviewing the key financial ratios for Everlon Financials Ltd โ Key Insights and Financials., here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 12, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 11) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 5. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For Diluted EPS (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 5. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For Cash EPS (Rs.), as of Mar 12, the value is 2.26. This value is below the healthy minimum of 3. It has increased from 2.21 (Mar 11) to 2.26, marking an increase of 0.05.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 12, the value is 8.47. It has increased from 6.85 (Mar 11) to 8.47, marking an increase of 1.62.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 12, the value is 8.47. It has increased from 6.85 (Mar 11) to 8.47, marking an increase of 1.62.
- For Revenue From Operations / Share (Rs.), as of Mar 12, the value is 84.38. It has increased from 51.90 (Mar 11) to 84.38, marking an increase of 32.48.
- For PBDIT / Share (Rs.), as of Mar 12, the value is 2.49. This value is within the healthy range. It has decreased from 3.21 (Mar 11) to 2.49, marking a decrease of 0.72.
- For PBIT / Share (Rs.), as of Mar 12, the value is 1.86. This value is within the healthy range. It has decreased from 2.13 (Mar 11) to 1.86, marking a decrease of 0.27.
- For PBT / Share (Rs.), as of Mar 12, the value is 2.03. This value is within the healthy range. It has increased from 1.30 (Mar 11) to 2.03, marking an increase of 0.73.
- For Net Profit / Share (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 2. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For NP After MI And SOA / Share (Rs.), as of Mar 12, the value is 1.63. This value is below the healthy minimum of 2. It has increased from 1.13 (Mar 11) to 1.63, marking an increase of 0.50.
- For PBDIT Margin (%), as of Mar 12, the value is 2.94. This value is below the healthy minimum of 10. It has decreased from 6.19 (Mar 11) to 2.94, marking a decrease of 3.25.
- For PBIT Margin (%), as of Mar 12, the value is 2.20. This value is below the healthy minimum of 10. It has decreased from 4.11 (Mar 11) to 2.20, marking a decrease of 1.91.
- For PBT Margin (%), as of Mar 12, the value is 2.40. This value is below the healthy minimum of 10. It has decreased from 2.50 (Mar 11) to 2.40, marking a decrease of 0.10.
- For Net Profit Margin (%), as of Mar 12, the value is 1.93. This value is below the healthy minimum of 5. It has decreased from 2.18 (Mar 11) to 1.93, marking a decrease of 0.25.
- For NP After MI And SOA Margin (%), as of Mar 12, the value is 1.93. This value is below the healthy minimum of 8. It has decreased from 2.18 (Mar 11) to 1.93, marking a decrease of 0.25.
- For Return on Networth / Equity (%), as of Mar 12, the value is 19.27. This value is within the healthy range. It has increased from 16.51 (Mar 11) to 19.27, marking an increase of 2.76.
- For Return on Capital Employeed (%), as of Mar 12, the value is 10.47. This value is within the healthy range. It has decreased from 17.68 (Mar 11) to 10.47, marking a decrease of 7.21.
- For Return On Assets (%), as of Mar 12, the value is 6.11. This value is within the healthy range. It has increased from 5.53 (Mar 11) to 6.11, marking an increase of 0.58.
- For Long Term Debt / Equity (X), as of Mar 12, the value is 1.05. This value exceeds the healthy maximum of 1. It has increased from 0.73 (Mar 11) to 1.05, marking an increase of 0.32.
- For Total Debt / Equity (X), as of Mar 12, the value is 1.73. This value exceeds the healthy maximum of 1. It has increased from 1.15 (Mar 11) to 1.73, marking an increase of 0.58.
- For Asset Turnover Ratio (%), as of Mar 12, the value is 3.57. It has increased from 3.18 (Mar 11) to 3.57, marking an increase of 0.39.
- For Current Ratio (X), as of Mar 12, the value is 1.74. This value is within the healthy range. It has increased from 1.33 (Mar 11) to 1.74, marking an increase of 0.41.
- For Quick Ratio (X), as of Mar 12, the value is 0.65. This value is below the healthy minimum of 1. It has decreased from 0.68 (Mar 11) to 0.65, marking a decrease of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 12, the value is 10.05. This value exceeds the healthy maximum of 8. It has decreased from 12.88 (Mar 11) to 10.05, marking a decrease of 2.83.
- For Interest Coverage Ratio (X), as of Mar 12, the value is 2.13. This value is below the healthy minimum of 3. It has decreased from 3.86 (Mar 11) to 2.13, marking a decrease of 1.73.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 12, the value is 1.26. This value is below the healthy minimum of 3. It has decreased from 2.25 (Mar 11) to 1.26, marking a decrease of 0.99.
- For Enterprise Value (Cr.), as of Mar 12, the value is 12.15. It has increased from 10.63 (Mar 11) to 12.15, marking an increase of 1.52.
- For EV / Net Operating Revenue (X), as of Mar 12, the value is 0.28. This value is below the healthy minimum of 1. It has decreased from 0.40 (Mar 11) to 0.28, marking a decrease of 0.12.
- For EV / EBITDA (X), as of Mar 12, the value is 9.67. This value is within the healthy range. It has increased from 6.55 (Mar 11) to 9.67, marking an increase of 3.12.
- For MarketCap / Net Operating Revenue (X), as of Mar 12, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 11) to 0.11, marking a decrease of 0.15.
- For Price / BV (X), as of Mar 12, the value is 1.18. This value is within the healthy range. It has decreased from 2.01 (Mar 11) to 1.18, marking a decrease of 0.83.
- For Price / Net Operating Revenue (X), as of Mar 12, the value is 0.11. This value is below the healthy minimum of 1. It has decreased from 0.26 (Mar 11) to 0.11, marking a decrease of 0.15.
- For EarningsYield, as of Mar 12, the value is 0.16. This value is below the healthy minimum of 5. It has increased from 0.08 (Mar 11) to 0.16, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Everlon Financials Ltd โ Key Insights and Financials.:
- Net Profit Margin: 1.93%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.47% (Industry Average ROCE: 15.8%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.27% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.26
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.65
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 52.25)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.73
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 1.93%
FAQ
What is the intrinsic value of Everlon Financials Ltd โ Key Insights and Financials.?
Everlon Financials Ltd โ Key Insights and Financials.'s intrinsic value (as of 09 December 2025) is 22.79 which is 80.35% lower the current market price of 116.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 71.8 Cr. market cap, FY2025-2026 high/low of 168/92.8, reserves of โน18.41 Cr, and liabilities of 28.13 Cr.
What is the Market Cap of Everlon Financials Ltd โ Key Insights and Financials.?
The Market Cap of Everlon Financials Ltd โ Key Insights and Financials. is 71.8 Cr..
What is the current Stock Price of Everlon Financials Ltd โ Key Insights and Financials. as on 09 December 2025?
The current stock price of Everlon Financials Ltd โ Key Insights and Financials. as on 09 December 2025 is 116.
What is the High / Low of Everlon Financials Ltd โ Key Insights and Financials. stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Everlon Financials Ltd โ Key Insights and Financials. stocks is 168/92.8.
What is the Stock P/E of Everlon Financials Ltd โ Key Insights and Financials.?
The Stock P/E of Everlon Financials Ltd โ Key Insights and Financials. is .
What is the Book Value of Everlon Financials Ltd โ Key Insights and Financials.?
The Book Value of Everlon Financials Ltd โ Key Insights and Financials. is 39.7.
What is the Dividend Yield of Everlon Financials Ltd โ Key Insights and Financials.?
The Dividend Yield of Everlon Financials Ltd โ Key Insights and Financials. is 0.00 %.
What is the ROCE of Everlon Financials Ltd โ Key Insights and Financials.?
The ROCE of Everlon Financials Ltd โ Key Insights and Financials. is 16.7 %.
What is the ROE of Everlon Financials Ltd โ Key Insights and Financials.?
The ROE of Everlon Financials Ltd โ Key Insights and Financials. is 4.69 %.
What is the Face Value of Everlon Financials Ltd โ Key Insights and Financials.?
The Face Value of Everlon Financials Ltd โ Key Insights and Financials. is 10.0.